Literature DB >> 26722498

Hyperbaric oxygen treatment ameliorates lung injury in paraquat intoxicated rats.

Raziye Akcılar1, Aydın Akcılar2, Hasan Şimşek1, Fatma Emel Koçak3, Cengiz Koçak4, Gündüz Yümün5, Zeynep Bayat6.   

Abstract

Paraquat (PQ) is an agrochemical agent commonly used worldwide, which can cause acute lung injury (ALI) and death. Hyperbaric oxygen treatment (HBOT) is a therapeutic method, but the mechanisms of the protective effect of HBOT on ALI remain elusive. The purpose of this study was to evaluate the effect of HBOT on acute lung injury induced by PQ in rats. Wistar Albino rats (n=21) were separated into three groups of seven animals each: control (C), PQ, and PQ + HBOT groups. 20 mg/kg PQ was administered intraperitoneally in PQ and PQ + HBOT groups to induce experimental lung injury. Three days after PQ treatment, PQ + HBOT group was administered 100% O2 at 2.0 ATA for 1 hour per day, for five consecutive days. At the end of the study, lung tissue was obtained for determining total oxidant status (TOS), total antioxidant status (TAS), oxidative stress index (OSI) and histopathological determination. Tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-β1 mRNA levels were assessed by quantitative reverse transcription-polymerase chain reaction. In addition, the inducible nitric oxide synthase (iNOS) level in the plasma was determined. Plasma iNOS, OSI, tissue TNF-α, TGF-β1 and bFGF mRNA levels, and histological injury scores in PQ + HBOT group were significantly lower than PQ group. TAS level in PQ + HBOT group was significantly higher than PQ group. The findings suggest that HBOT could effectively ameliorate PQ-induced lung injury in rats.

Entities:  

Keywords:  Paraquat; antioxidant; hyperbaric oxygen treatment; lung injury; oxidant

Mesh:

Substances:

Year:  2015        PMID: 26722498      PMCID: PMC4680443     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  46 in total

1.  Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen.

Authors:  A L Harabin; J C Braisted; E T Flynn
Journal:  J Appl Physiol (1985)       Date:  1990-07

2.  Recruitment maneuver in experimental acute lung injury: the role of alveolar collapse and edema.

Authors:  Viviane R Santiago; Andréia F Rzezinski; Liliane M Nardelli; Johnatas D Silva; Cristiane S N B Garcia; Tatiana Maron-Gutierrez; Debora S Ornellas; Marcelo M Morales; Vera L Capelozzi; John Marini; Paolo Pelosi; Patricia R M Rocco
Journal:  Crit Care Med       Date:  2010-11       Impact factor: 7.598

3.  Pulmonary protective effects of curcumin against paraquat toxicity.

Authors:  N Venkatesan
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

4.  Therapeutic efficacy of ozone in patients with diabetic foot.

Authors:  Gregorio Martínez-Sánchez; Saied M Al-Dalain; Silvia Menéndez; Lamberto Re; Attilia Giuliani; Eduardo Candelario-Jalil; Hector Alvarez; José Ignacio Fernández-Montequín; Olga Sonia León
Journal:  Eur J Pharmacol       Date:  2005-09-29       Impact factor: 4.432

Review 5.  Hyperbaric oxygen therapy for chronic wounds.

Authors:  P Kranke; M Bennett; I Roeckl-Wiedmann; S Debus
Journal:  Cochrane Database Syst Rev       Date:  2004

6.  Hyperbaric oxygen reduces matrix metalloproteinases in ischemic wounds through a redox-dependent mechanism.

Authors:  Qixu Zhang; Lisa J Gould
Journal:  J Invest Dermatol       Date:  2013-07-18       Impact factor: 8.551

Review 7.  Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome.

Authors:  Sadatomo Tasaka; Fumimasa Amaya; Satoru Hashimoto; Akitoshi Ishizaka
Journal:  Antioxid Redox Signal       Date:  2008-04       Impact factor: 8.401

8.  Differential paraquat uptake and redox kinetics of rat granular pneumocytes and alveolar macrophages.

Authors:  H J Forman; T K Aldrich; M A Posner; A B Fisher
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

9.  Effect of transforming growth factor-β1 on acute lung injury caused by paraquat.

Authors:  Baotian Kan; Xiangdong Jian; Qian Zhou; Jieru Wang; Guangcai Yu; Jing Sun; Yikai Gao
Journal:  Mol Med Rep       Date:  2014-02-07       Impact factor: 2.952

10.  Suppression of tumor necrosis factor-alpha and inducible nitric oxide synthase gene expression by THI 52, a new synthetic naphthyl-benzylisoquinoline alkaloid.

Authors:  Young J Kang; Bog K Lee; Young S Lee; Han G Seo; Min K Park; Hyo J Kim; Hyang S Pyo; Won S Chong; Hye J Jung; Hye S Yun-Choi; Duck H Lee; Ki C Chang
Journal:  Biochem Pharmacol       Date:  2003-02-01       Impact factor: 5.858

View more
  5 in total

Review 1.  Delayed death following paraquat poisoning: three case reports and a literature review.

Authors:  Shahin Shadnia; Alireza Ebadollahi-Natanzi; Saeid Ahmadzadeh; Somayyeh Karami-Mohajeri; Yaghoub Pourshojaei; Hamid Reza Rahimi
Journal:  Toxicol Res (Camb)       Date:  2018-06-12       Impact factor: 3.524

2.  Salvianolic acid B attenuates lipopolysaccharide-induced acute lung injury in rats through inhibition of apoptosis, oxidative stress and inflammation.

Authors:  Da-Hai Zhao; Yu-Jie Wu; Shu-Ting Liu; Rong-Yu Liu
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

3.  Effects of Ovariohysterectomy and Hyperbaric Oxygen Therapy on Systemic Inflammation and Oxidation in Dogs.

Authors:  Anais Gautier; Emily C Graff; Lenore Bacek; Eric J Fish; Amelia White; Lee Palmer; Kendon Kuo
Journal:  Front Vet Sci       Date:  2020-01-15

4.  Histopathological Study of Cyclosporine Pulmonary Toxicity in Rats.

Authors:  Said Said Elshama; Ayman El-Meghawry El-Kenawy; Hosam-Eldin Hussein Osman
Journal:  J Toxicol       Date:  2016-01-28

5.  Thal protects against paraquat-induced lung injury through a microRNA-141/HDAC6/IκBα-NF-κB axis in rat and cell models.

Authors:  Fenshuang Zheng; Junbo Zhu; Wei Zhang; Yangshan Fu; Zhaoheng Lin
Journal:  Basic Clin Pharmacol Toxicol       Date:  2020-10-14       Impact factor: 4.080

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.